Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net loss	$ (4,957,165)	$ (5,207,994)
Adjustments for:
Depreciation and amortization	93,405	141,843
Share-based compensation	325,217	443,559
Gain on loan forgiveness	0	(14,766)
Changes in working capital items:
Accounts and other receivable	(18,159)	71,501
Prepaid expenses and other current assets	73,355	109,647
Accounts payable and accrued liabilities	(1,117,921)	533,044
Net cash used in operating activities	(5,601,268)	(3,923,166)
Cash flows from financing activities:
Proceeds from issuance of common shares and warrants	7,497,133	729,387
Proceeds from issuance of Series A-1 preferred shares and warrants	1,540,820	0
Payment for issuance costs of warrants	(23,446)	0
Repayment of debt	0	(29,532)
Net cash provided by financing activities	16,844,415	623,466
Effect of exchange rate changes on cash and cash equivalents	81,223	(20,813)
Net change in cash and cash equivalents	11,324,370	(3,320,513)
Cash and cash equivalents, beginning of period	1,037,320	5,361,397
Cash and cash equivalents, end of period	12,361,690	2,040,884
Series B-1 Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Series B-1 preferred shares	8,340,000	0
Common Stock and Warrants [Member]
Cash flows from financing activities:
Payments for issuance costs	(294,935)	(76,389)
Preferred Stock [Member]
Cash flows from financing activities:
Payments for issuance costs	$ (215,157)	$ 0